From 5th to 7th of April, 2022, BOAI NKY PHARMACEUTICALS LTD., a subsidiary company of Boai NKY Medical Holdings Ltd. (Stock Code: 300109), took part in the “in-cosmetics®Global” global personal cosmetics raw materials exhibition with a few new products. In this event, NKY released three new co-polymer products: PoliRez®, Nokesho® and DermaRez®, in which DermaRez® is a raw material product NKY has developed for skin care application. These new products launched this time enrich the variety of NKY products and provide customers of NKY with more options.
The political and business delegation from California state which participated in Henan International Investment Fair, made a visit to Boai NKY under the leadership of Mayor Pro Tem Samuel Kang (City of Duarte, CA) in the afternoon of April 6th, 2019.
Dr. Herbert Ulmer (fifth from right), chief scientist of Boai NKY. Mr. Wojciech Bobecki (fourth from right), deputy GM of Boai NKY-Germany branch. Mr. Wang long (third from right), GM assistant of Tianjin Boai NKY international ltd., and staffs from Narda Tita.
A new R&D centre with occupied area of 6200 ? has been put into operation at headquarter of Boai NKY which is located in jiaozuo, China. By using most advanced synthesis, process and analytical equipment, the new R&D centre will highly improve our new product development and customer service capabilities.
Notification of the renaming of Boai NKY Pharmaceuticals Ltd.
NKY PRECISION MEDICINE and the thousands of thousands of German guests gathered at the foot of xiangshan, the first step in a new open source collaboration with Heidelberg university medical school.
Successful ending of Boai NKY 2017 autumn tourism in Japan and Zhang jiajie
In October 24th, the world pharmaceutical raw materials exhibition (CPhI Worldwide) was held in Frankfurt, Germany, in 2017. NKY medical group (NKY, stock code: 300109) subsidiary Boai NKY Pharmaceuticals Limited attend this global pharmaceutical industry event with a new attitude - the large special booth, 11 line up of international marketing team (including 5 employees from different countries overseas ) to participate in this event. Introduce the advanced and perfect products to the customers of the world with the new market strategy.
Invited by the NKY medical group, the chief executive of Swedish NeoDynamics , Anna Eriksrud visit Beijing on 18~21th September. NeoDynamics is a medical technology company headquartered in Sweden, which is committed to research and develop tumor diagnosis equipment. NeoDynamics has now developed NeoNavia breast biopsy system, and in June 2016 acquired the European Union CE certification. From July 2016, NKY become the biggest shareholder in the NeoDynamics.